NeuroPace(NPCE)
$12.69+-0.43 (+1.52%)
NPCE
NeuroPace financials statements
$12.69
At close:+-0.43 (+1.52%)
Want to see NPCE full AI Analyst Report?
NeuroPace (NPCE) Ratios
143 Followers
NeuroPace Ratios
NPCE's free cash flow for Q2 2026 was $-4.03M. For the 2026 fiscal year, NPCE's free cash flow was decreased by $-125.00K and operating cash flow was $-3.90M. See a summary of the company’s cash flow.
| Ratios | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| Liquidity Ratios | |||||
| Current Ratio | 5.28 | 5.37 | 5.71 | 8.90 | 14.28 |
| Quick Ratio | 4.33 | 4.48 | 5.02 | 8.02 | 13.44 |
| Cash Ratio | 1.22 | 0.89 | 1.11 | 0.60 | 2.06 |
| Solvency Ratio | -0.23 | -0.29 | -0.36 | -0.56 | -0.60 |
| Operating Cash Flow Ratio | -0.62 | -1.18 | -1.21 | -3.36 | -2.64 |
| Short-Term Operating Cash Flow Coverage | -5.20 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Current Asset Value | $ 7.54M | $ -5.29M | $ 5.72M | $ 18.39M | $ 72.76M |
| Leverage Ratios | |||||
| Debt-to-Assets Ratio | 0.67 | 0.77 | 0.67 | 0.61 | 0.37 |
| Debt-to-Equity Ratio | 3.72 | 9.15 | 3.51 | 2.01 | 0.68 |
| Debt-to-Capital Ratio | 0.79 | 0.90 | 0.78 | 0.67 | 0.40 |
| Long-Term Debt-to-Capital Ratio | 0.76 | 0.88 | 0.73 | 0.60 | 0.40 |
| Financial Leverage Ratio | 5.55 | 11.81 | 5.21 | 3.28 | 1.82 |
| Debt Service Coverage Ratio | -1.26 | -1.88 | -2.68 | -4.86 | -3.83 |
| Interest Coverage Ratio | -2.19 | -2.46 | -3.19 | -5.42 | -3.20 |
| Debt to Market Cap | 0.12 | 0.18 | 0.21 | 1.44 | 0.30 |
| Interest Debt Per Share | 2.39 | 2.82 | 3.13 | 3.14 | 3.45 |
| Net Debt to EBITDA | -4.08 | -3.61 | -2.38 | -1.73 | -1.08 |
| Profitability Margins | |||||
| Gross Profit Margin | 77.23% | 73.94% | 73.56% | 71.38% | 74.00% |
| EBIT Margin | -14.01% | -22.96% | -37.36% | -86.89% | -63.45% |
| EBITDA Margin | -12.06% | -20.74% | -34.90% | -80.33% | -62.80% |
| Operating Profit Margin | -16.34% | -27.12% | -41.54% | -89.62% | -52.54% |
| Pretax Profit Margin | -21.47% | -33.97% | -50.38% | -103.43% | -79.85% |
| Net Profit Margin | -21.47% | -33.97% | -50.38% | -103.43% | -79.85% |
| Continuous Operations Profit Margin | -21.47% | -33.97% | -50.38% | -103.43% | -79.85% |
| Net Income Per EBT | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% |
| EBT Per EBIT | 131.38% | 125.24% | 121.28% | 115.41% | 152.00% |
| Return on Assets (ROA) | -20.33% | -28.68% | -30.61% | -41.26% | -27.01% |
| Return on Equity (ROE) | -112.79% | -338.71% | -159.56% | -135.38% | -49.09% |
| Return on Capital Employed (ROCE) | -18.62% | -27.26% | -29.72% | -39.56% | -19.10% |
| Return on Invested Capital (ROIC) | -18.18% | -26.64% | -29.20% | -39.02% | -19.10% |
| Return on Tangible Assets | -20.33% | -28.68% | -30.61% | -41.26% | -27.01% |
| Earnings Yield | -4.25% | -8.33% | -12.36% | -128.48% | -21.55% |
| Efficiency Ratios | |||||
| Receivables Turnover | 6.81 | 6.22 | 5.31 | 6.08 | 6.37 |
| Payables Turnover | 10.27 | 7.05 | 7.42 | 6.07 | 8.53 |
| Inventory Turnover | 1.35 | 1.56 | 1.54 | 1.34 | 1.50 |
| Fixed Asset Turnover | 8.88 | 6.20 | 4.54 | 2.86 | 74.93 |
| Asset Turnover | 0.95 | 0.84 | 0.61 | 0.40 | 0.34 |
| Working Capital Turnover Ratio | 1.40 | 1.12 | 0.80 | 0.43 | 0.54 |
| Cash Conversion Cycle | 288.94 | 241.49 | 256.11 | 271.96 | 257.49 |
| Days of Sales Outstanding | 53.59 | 58.70 | 68.70 | 59.99 | 57.28 |
| Days of Inventory Outstanding | 270.89 | 234.57 | 236.61 | 272.12 | 243.02 |
| Days of Payables Outstanding | 35.54 | 51.78 | 49.20 | 60.16 | 42.81 |
| Operating Cycle | 324.48 | 293.28 | 305.31 | 332.11 | 300.31 |
| Cash Flow Ratios | |||||
| Operating Cash Flow Per Share | -0.34 | -0.62 | -0.76 | -1.50 | -1.48 |
| Free Cash Flow Per Share | -0.35 | -0.63 | -0.77 | -1.52 | -1.50 |
| Dividend Paid and CapEx Coverage Ratio | -33.15 | -58.66 | -113.88 | -61.14 | -64.00 |
| Capital Expenditure Coverage Ratio | -33.15 | -58.66 | -113.88 | -61.14 | -64.00 |
| Operating Cash Flow Coverage Ratio | -0.16 | -0.24 | -0.27 | -0.53 | -0.49 |
| Operating Cash Flow to Sales Ratio | -0.11 | -0.22 | -0.30 | -0.81 | -0.54 |
| Free Cash Flow Yield | -2.24% | -5.60% | -7.46% | -102.25% | -14.91% |
| Valuation Ratios | |||||
| Price-to-Earnings (P/E) Ratio | -23.39 | -12.03 | -8.09 | -0.78 | -4.64 |
| Price-to-Sales (P/S) Ratio | 5.05 | 4.08 | 4.07 | 0.81 | 3.71 |
| Price-to-Book (P/B) Ratio | 26.55 | 40.67 | 12.90 | 1.05 | 2.28 |
| Price-to-Free Cash Flow (P/FCF) Ratio | -44.56 | -17.85 | -13.41 | -0.98 | -6.71 |
| Price-to-Operating Cash Flow Ratio | -45.91 | -18.16 | -13.53 | -0.99 | -6.81 |
| Price-to-Earnings Growth (PEG) Ratio | 0.81 | 0.45 | 0.24 | 0.06 | 0.00 |
| Enterprise Value Multiple | -45.97 | -23.28 | -14.05 | -2.73 | -6.98 |
| Enterprise Value | 554.38M | 385.83M | 320.87M | 99.81M | 198.08M |
| EV to EBITDA | -45.97 | -23.28 | -14.05 | -2.73 | -6.98 |
| EV to Sales | 5.54 | 4.83 | 4.90 | 2.19 | 4.38 |
| EV to Free Cash Flow | -48.90 | -21.14 | -16.15 | -2.66 | -7.94 |
| EV to Operating Cash Flow | -50.37 | -21.50 | -16.29 | -2.71 | -8.06 |
| Tangible Book Value Per Share | 0.58 | 0.28 | 0.80 | 1.41 | 4.43 |
| Shareholders’ Equity Per Share | 0.58 | 0.28 | 0.80 | 1.41 | 4.43 |
| Tax and Other Ratios | |||||
| Effective Tax Rate | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Revenue Per Share | 3.06 | 2.74 | 2.53 | 1.85 | 2.72 |
| Net Income Per Share | -0.66 | -0.93 | -1.27 | -1.91 | -2.17 |
| Tax Burden | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 |
| Interest Burden | 1.53 | 1.48 | 1.35 | 1.19 | 1.26 |
| Research & Development to Revenue | 0.28 | 0.30 | 0.32 | 0.48 | 0.40 |
| SG&A to Revenue | 0.66 | 0.71 | 0.00 | 0.00 | 0.00 |
| Stock-Based Compensation to Revenue | 0.11 | 0.13 | 0.15 | 0.18 | 0.09 |
| Income Quality | 0.51 | 0.66 | 0.60 | 0.78 | 0.68 |
Currency in USD
